In contrast to the primarily anti-inflammatory effect of SP-D in the lung, during development of mouse atherosclerosis the major impact of SP-D appears to be enhancement of inflammation (48, 457) and this is also the case during fetoplacental development (331). This evidence concerns the gene SFTPD and atherosclerosis.